Lugar de publicación Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop. 5:e1186323. 2016 PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy. 1:86-88. 2012
